Author

S. Namkoong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

C. H. Kim· 1 shared E. Yoon· 1 shared H. Kwak· 1 shared H. M. Kang· 1 shared J. H. Lee· 1 shared J. I. Lee· 1 shared J. Park· 1 shared L. Friesen· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. H. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro

M. Jang, Y.-I. Park, R. Park, Y.-E. Cha, S. Namkoong, J. I. Lee, J. Park

This study shows lopinavir and ritonavir do not inhibit SARS-CoV-2 main protease activity in vitro, suggesting they may not be effective for COVID-19 treatment.

bioRxiv · Sep 16, 2020 · PreprintMicrobiology

Heterogeneous transcriptome response to DNA damage at single cell resolution.

S. R. Park, S. Namkoong, Z. Z. Zhang, L. Friesen, Y.-C. Chen, E. Yoon, C. H. Kim, H. Kwak, H. M. Kang, J. H. Lee

The paper shows that DNA damage induces heterogeneous transcriptome responses in cancer cells, with distinct transcriptional programs dictating cell fate outcomes such as checkpoint, apoptosis, or chemoresistance.

bioRxiv · Aug 15, 2019Cell Biology